Understanding and modeling myelodysplastic syndromes in patients.
Modeling myelodysplasia
This study is creating a special mouse model to help researchers understand myelodysplastic syndromes (MDS) better and find new treatments, so that patients with this blood cancer can have more effective options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11005209 on NIH RePORTER |
What this research studies
This research focuses on myelodysplastic syndromes (MDS), a type of blood cancer that affects the stem cells responsible for producing blood cells. The study aims to develop a new mouse model that mimics human MDS, allowing researchers to test new treatments more effectively. By analyzing patient samples and their responses to existing therapies like azacitidine, the research seeks to uncover the underlying mechanisms of resistance and disease progression. This approach could lead to the identification of more effective treatment strategies for patients suffering from MDS.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with myelodysplastic syndromes, particularly older adults and cancer survivors.
Not a fit: Patients with other types of blood cancers or those who do not have myelodysplastic syndromes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for patients with myelodysplastic syndromes.
How similar studies have performed: Previous research has shown promise in using similar mouse models for studying blood cancers, indicating potential for success in this approach.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Grimes, H. Leighton — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Grimes, H. Leighton
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.